Haferlach T - Search Results

1

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.

Simonetti G, Padella A, do Valle IF, Fontana MC, Fonzi E, Bruno S, Baldazzi C, Guadagnuolo V, Manfrini M, Ferrari A, Paolini S, Papayannidis C, Marconi G, Franchini E, Zuffa E, Laginestra MA, Zanotti F, Astolfi A, Iacobucci I, Bernardi S, Sazzini M, Ficarra E, Hernandez JM, Vandenberghe P, Cools J, Bullinger L, Ottaviani E, Testoni N, Cavo M, Haferlach T, Castellani G, Remondini D, Martinelli G. Simonetti G, et al. Among authors: haferlach t. Cancer. 2019 Mar 1;125(5):712-725. doi: 10.1002/cncr.31837. Epub 2018 Nov 27. Cancer. 2019. PMID: 30480765 Free PMC article.

2

Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.

Schoch C, Haferlach T, Bursch S, Gerstner D, Schnittger S, Dugas M, Kern W, Löffler H, Hiddemann W. Schoch C, et al. Among authors: haferlach t. Genes Chromosomes Cancer. 2002 Sep;35(1):20-9. doi: 10.1002/gcc.10088. Genes Chromosomes Cancer. 2002. PMID: 12203786

3

Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.

Zada AA, Singh SM, Reddy VA, Elsässer A, Meisel A, Haferlach T, Tenen DG, Hiddemann W, Behre G. Zada AA, et al. Among authors: haferlach t. Oncogene. 2003 Apr 17;22(15):2296-308. doi: 10.1038/sj.onc.1206393. Oncogene. 2003. PMID: 12700665

4

Molecular characterization of acute leukemias by use of microarray technology.

Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T. Kohlmann A, et al. Among authors: haferlach t. Genes Chromosomes Cancer. 2003 Aug;37(4):396-405. doi: 10.1002/gcc.10225. Genes Chromosomes Cancer. 2003. PMID: 12800151

5

Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.

Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C. Klaus M, et al. Among authors: haferlach t. Cancer Genet Cytogenet. 2004 Nov;155(1):47-56. doi: 10.1016/j.cancergencyto.2004.03.008. Cancer Genet Cytogenet. 2004. PMID: 15527902

6

AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.

Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, Schoch C. Haferlach T, et al. Genes Chromosomes Cancer. 2005 Jun;43(2):113-27. doi: 10.1002/gcc.20175. Genes Chromosomes Cancer. 2005. PMID: 15751046

7

Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile.

Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T. Schoch C, et al. Among authors: haferlach t. Genes Chromosomes Cancer. 2005 Jul;43(3):227-38. doi: 10.1002/gcc.20193. Genes Chromosomes Cancer. 2005. PMID: 15846790 Review.

8

Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.

Bacher U, Kern W, Schoch C, Schnittger S, Hiddemann W, Haferlach T. Bacher U, et al. Among authors: haferlach t. Cancer. 2006 Feb 15;106(4):839-47. doi: 10.1002/cncr.21665. Cancer. 2006. PMID: 16419072 Free article.

9

New insights into the biology of acute myeloid leukemia and their impact on treatment.

Hiddemann W, Haferlach T, Schoch C, Behre G, Kohlmann A, Kern W, Feuring-Buske M, Bohlander S. Hiddemann W, et al. Among authors: haferlach t. Verh Dtsch Ges Pathol. 2003;87:72-8. Verh Dtsch Ges Pathol. 2003. PMID: 16888897

10

Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.

Kern W, Kohlmann A, Schoch C, Schnittger S, Haferlach T. Kern W, et al. Among authors: haferlach t. Cancer. 2006 Nov 15;107(10):2401-7. doi: 10.1002/cncr.22251. Cancer. 2006. PMID: 17041886 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

712 results

Search Page